TOFACITINIB CITRATE | A218096 | APOTEX INC
2 strengths0 unique patents0 unique exclusivities
Reference Listed Drug: XELJANZ(TE code: AB) Products (2)
Sort:
No patent or exclusivity listings for this strength.
ADDED7/1/2026
Apotex's tofacitinib citrate product (NDA 218096, strength 001) was added to Drugs@FDA.
ADDED7/1/2026
Apotex's abbreviated new drug application for tofacitinib citrate (ANDA 218096, supplement 002) was added to the FDA database.